### Hyperactive chemotaxis contributes to anti-TNFα treatment resistance in inflammatory bowel disease

#### Table of Contents
##### A. IBD patients data with anti-TNFα treatment response 
(GSE16879, GSE23597, GSE52746, GSE73661 & GSE92415)

[01. Expression microarray data normalisation](https://github.com/paytonyau/anti-TNF-resistance/blob/main/01.microarray.normalisation.R)

[02. Data integration and batch effect correction](https://github.com/paytonyau/anti-TNF-resistance/blob/main/02.ComBat.SVA.R)

[03. In silico flow cytometry analysis](https://github.com/paytonyau/anti-TNF-resistance/blob/main/03A.MCP-Counter.R)

[04. t-test Loop](https://github.com/paytonyau/anti-TNF-resistance/blob/main/04_T-Test.R)

[05. Three-dimensional plot](https://github.com/paytonyau/anti-TNF-resistance/blob/main/05_3D_Plot.R)

[06. Differentially expressed genes analysis](https://github.com/paytonyau/anti-TNF-resistance/blob/main/06_DEGs.R)

[07. ROC loop](https://github.com/paytonyau/anti-TNF-resistance/blob/main/07_ROC.curves.R)

##### B. Expermintal data on LPS - Neutrophils (GSE145918)

[08. RNA-seq data normalisation](https://github.com/paytonyau/anti-TNF-resistance/blob/main/08_LPS_Neutrophils_RNA-seq_Norm.R)

[09. Matched GO term calculation](https://github.com/paytonyau/anti-TNF-resistance/blob/main/09_LPS_Neutrophils_Groups_Comparsions.R)


Detailed explanation can be found on the manuscript (currenly under review).
